首页> 外国专利> COMPOSITION FOR TREATING PROTEASOME INHIBITOR-RESISTANT CANCER, KIT FOR TREATMENT, AND SCREENING METHOD OF COMPOUND FOR TREATING PROTEASOME INHIBITOR-RESISTANT CANCER

COMPOSITION FOR TREATING PROTEASOME INHIBITOR-RESISTANT CANCER, KIT FOR TREATMENT, AND SCREENING METHOD OF COMPOUND FOR TREATING PROTEASOME INHIBITOR-RESISTANT CANCER

机译:用于治疗抗癌药的组合物,用于治疗的工具包以及用于治疗抗癌药的化合物的筛选方法

摘要

PPROBLEM TO BE SOLVED: To provide a composition for treating a proteasome inhibitor-resistant cancer, a screening method thereof, or the like by way of precaution against appearance of a proteasome inhibitor-resistant cancer cell. PSOLUTION: The composition for treating the proteasome inhibitor-resistant cancer comprises as an effective ingredient fluorouracil, a prodrug thereof, or a salt thereof, or a topoisomerase inhibitor or a salt thereof. The screening method of the compound for treating the proteasome inhibitor-resistant cancer utilizes a cell caused to have acquired resistance to a proteasome inhibitor. PCOPYRIGHT: (C)2007,JPO&INPIT
机译:<解决的问题:通过预防蛋白酶体抑制剂抗性癌细胞的出现,提供用于治疗蛋白酶体抑制剂抗性癌症的组合物,其筛选方法等。 <解决方案>用于治疗抗蛋白酶体抑制剂的癌症的组合物包含氟尿嘧啶,其前药或其盐,或拓扑异构酶抑制剂或其盐作为有效成分。用于治疗抗蛋白酶体抑制剂的癌症的化合物的筛选方法利用引起对蛋白酶体抑制剂具有抗性的细胞。

版权:(C)2007,日本特许厅&INPIT

著录项

  • 公开/公告号JP2007001881A

    专利类型

  • 公开/公告日2007-01-11

    原文格式PDF

  • 申请/专利权人 OKAWA KIYOSHI;

    申请/专利号JP20050180494

  • 发明设计人 OKAWA KIYOSHI;

    申请日2005-06-21

  • 分类号A61K31/513;A61K31/7072;A61P43;A61K45;C12Q1/02;G01N33/15;G01N33/50;C12N9/99;C12N15/09;

  • 国家 JP

  • 入库时间 2022-08-21 21:15:15

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号